Biopharmaceuticals
Venture Capital
Personnel
News Release - September 1, 2015
Intellia Therapeutics Secures $70 Million in Series B Financing
Source: Intellia Therapeutics
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.